FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157 Erectile Dysfunction: What the Evidence Shows and Practical Considerations FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica